Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.85)
# 719
Out of 4,761 analysts
78
Total ratings
42.11%
Success rate
13.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $35.99 | +158.41% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $7.98 | +839.85% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.93 | +650.91% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $7.31 | +255.68% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $27.07 | +88.40% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $18.57 | +99.25% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $1.40 | +1,757.14% | 2 | Sep 19, 2024 | |
| SLRN Acelyrin | Maintains: Overweight | $68 → $20 | $2.60 | +669.23% | 2 | Aug 14, 2024 | |
| IMUX Immunic | Reiterates: Overweight | $28 | $1.27 | +2,104.72% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $37.46 | +158.94% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $74.49 | +262.46% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $29.54 | +157.28% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $6.43 | +288.80% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $11.30 | +165.49% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $4.91 | +144.40% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $67.96 | -47.03% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.62 | +1,358.91% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $26.29 | +584.67% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.40 | +971.43% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $336.23 | -0.07% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.69 | +494.80% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $18.59 | +330.34% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $46.13 | +101.60% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $23.77 | +291.33% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $12.21 | +432.35% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $21.27 | +167.98% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $4.12 | +1,526.21% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $38.75 | -9.68% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.29 | +7,600.39% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $8.03 | +983.44% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $94 | $15.56 | +504.11% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $18.63 | +839.35% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.71 | +1,308.45% | 1 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $50.26 | +43.26% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $3.08 | +776.62% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $11.06 | +71.79% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.61 | +3,005.59% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.11 | +3,503.60% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.71 | +2,422.78% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.59 | +3,464.76% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $17.77 | +333.31% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $52.45 | +46.81% | 1 | Jul 31, 2020 |
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $35.99
Upside: +158.41%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $7.98
Upside: +839.85%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.93
Upside: +650.91%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $7.31
Upside: +255.68%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $27.07
Upside: +88.40%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.57
Upside: +99.25%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.40
Upside: +1,757.14%
Acelyrin
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $2.60
Upside: +669.23%
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.27
Upside: +2,104.72%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $37.46
Upside: +158.94%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $74.49
Upside: +262.46%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $29.54
Upside: +157.28%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $6.43
Upside: +288.80%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $11.30
Upside: +165.49%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $4.91
Upside: +144.40%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $67.96
Upside: -47.03%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.62
Upside: +1,358.91%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $26.29
Upside: +584.67%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.40
Upside: +971.43%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $336.23
Upside: -0.07%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.69
Upside: +494.80%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $18.59
Upside: +330.34%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $46.13
Upside: +101.60%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $23.77
Upside: +291.33%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $12.21
Upside: +432.35%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $21.27
Upside: +167.98%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $4.12
Upside: +1,526.21%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $38.75
Upside: -9.68%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.29
Upside: +7,600.39%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $8.03
Upside: +983.44%
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $15.56
Upside: +504.11%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $18.63
Upside: +839.35%
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $0.71
Upside: +1,308.45%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $50.26
Upside: +43.26%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $3.08
Upside: +776.62%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $11.06
Upside: +71.79%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.61
Upside: +3,005.59%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.11
Upside: +3,503.60%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.71
Upside: +2,422.78%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.59
Upside: +3,464.76%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $17.77
Upside: +333.31%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $52.45
Upside: +46.81%